Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
- 1 October 2007
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 47 (4) , 499-505
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Circulatory function and hepatorenal syndrome in cirrhosis†Hepatology, 2005
- Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndromeHepatology, 2004
- Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized studyHepatology, 2002
- Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot studyHepatology, 2002
- Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II studyGut, 2000
- Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndromeJournal of Hepatology, 1998
- Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systemsHepatology, 1998
- Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansionHepatology, 1998
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†Hepatology, 1996
- IMPACT OF PRETRANSPLANT RENAL FUNCTION ON SURVIVAL AFTER LIVER TRANSPLANTATIONTransplantation, 1995